Table 2.
Short-term curative effects of all patients
| Curative effects | I+C (group A, n=59) | I (group B, n=75) | C (group C, n=57) |
|---|---|---|---|
| Best response | |||
| CR | 1.7% (n=1) | 0% (n=0) | 0% (n=0) |
| PR | 62.7% (n=37) | 46.7% (n=35) | 26.3% (n=15) |
| SD | 30.5% (n=18) | 45.3% (n=34) | 43.9% (n=25) |
| PD | 5.1% (n=3) | 8.0% (n=6) | 29.8% (n=17) |
| ORR (%) | 64.4 | 46.7 | 26.3 |
| DCR (%) | 94.9 | 92.0 | 70.2 |
Abbreviations: C, chemotherapy; CR, complete remission; DCR, disease control rate; I, icotinib; I+C, icotinib+chemotherapy; ORR, overall response rate; PD, progression disease; PR, partial disease; SD, stable disease.